These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 1398142

  • 1. A high-level expression vector for human cells.
    Subramanian T, Chinnadurai G.
    Gene; 1992 Oct 21; 120(2):287-9. PubMed ID: 1398142
    [Abstract] [Full Text] [Related]

  • 2. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
    Negrini M, Rimessi P, Sabbioni S, Caputo A, Balboni PG, Gualandri R, Manservigi R, Grossi MP, Barbanti-Brodano G.
    Biotechniques; 1991 Mar 21; 10(3):344-53. PubMed ID: 1829615
    [Abstract] [Full Text] [Related]

  • 3. Cellular factors regulate transactivation of human immunodeficiency virus type 1.
    Barry PA, Pratt-Lowe E, Unger RE, Luciw PA.
    J Virol; 1991 Mar 21; 65(3):1392-9. PubMed ID: 1995949
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
    Chuah MK, VandenDriessche T, Chang HK, Ensoli B, Morgan RA.
    Hum Gene Ther; 1994 Dec 21; 5(12):1467-75. PubMed ID: 7711139
    [Abstract] [Full Text] [Related]

  • 5. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.
    Scala G, Ruocco MR, Ambrosino C, Mallardo M, Giordano V, Baldassarre F, Dragonetti E, Quinto I, Venuta S.
    J Exp Med; 1994 Mar 01; 179(3):961-71. PubMed ID: 8113688
    [Abstract] [Full Text] [Related]

  • 6. Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication.
    Kessler M, Mathews MB.
    Proc Natl Acad Sci U S A; 1991 Nov 15; 88(22):10018-22. PubMed ID: 1658792
    [Abstract] [Full Text] [Related]

  • 7. A sensitive promoter assay based on the transcriptional activator Tat of the HIV-1 virus.
    Koken SE, van Wamel J, Berkhout B.
    Gene; 1994 Jul 08; 144(2):243-7. PubMed ID: 8039709
    [Abstract] [Full Text] [Related]

  • 8. Human immunodeficiency virus Tat transactivation: induction of a tissue-specific enhancer in a nonpermissive cell line.
    Remenick J, Radonovich MF, Brady JN.
    J Virol; 1991 Oct 08; 65(10):5641-6. PubMed ID: 1654461
    [Abstract] [Full Text] [Related]

  • 9. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L, Morris GF, Lockyer JM, Lu M, Wang Z, Morris CB.
    Virology; 1997 Aug 18; 235(1):48-64. PubMed ID: 9300036
    [Abstract] [Full Text] [Related]

  • 10. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
    Tiley LS, Madore SJ, Malim MH, Cullen BR.
    Genes Dev; 1992 Nov 18; 6(11):2077-87. PubMed ID: 1427073
    [Abstract] [Full Text] [Related]

  • 11. Green fluorescence protein as a transcriptional reporter for the long terminal repeats of the human immunodeficiency virus type 1.
    Kar-Roy A, Dong W, Michael N, Li Y.
    J Virol Methods; 2000 Feb 18; 84(2):127-38. PubMed ID: 10680962
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T, Kaushik N, Pandey PK, Kashanchi F, Deng L, Pandey VN.
    Biochemistry; 2000 Sep 26; 39(38):11532-9. PubMed ID: 10995220
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
    Mukhtar M, Duan L, Bagasra O, Pomerantz RJ.
    Gene Ther; 1996 Aug 26; 3(8):725-30. PubMed ID: 8854098
    [Abstract] [Full Text] [Related]

  • 14. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Robinson D, Elliott JF, Chang LJ.
    Gene Ther; 1995 Jun 26; 2(4):269-78. PubMed ID: 7552987
    [Abstract] [Full Text] [Related]

  • 15. Gene activation mediated by protein kinase C in human macrophage and teratocarcinoma cells expressing aminoglycoside phosphotransferase activity.
    Maio JJ, Brown FL.
    J Cell Physiol; 1991 Dec 26; 149(3):548-59. PubMed ID: 1660486
    [Abstract] [Full Text] [Related]

  • 16. Trans-activation of the long terminal repeat of human immunodeficiency virus type 1 by the parvovirus B19 NS1 gene product.
    Sol N, Morinet F, Alizon M, Hazan U.
    J Gen Virol; 1993 Sep 26; 74 ( Pt 9)():2011-4. PubMed ID: 8376975
    [Abstract] [Full Text] [Related]

  • 17. Transactivation of heterologous promoters by HIV-1 tat.
    Han P, Brown R, Barsoum J.
    Nucleic Acids Res; 1991 Dec 26; 19(25):7225-9. PubMed ID: 1662814
    [Abstract] [Full Text] [Related]

  • 18. Reciprocal in vitro interactions between human herpesvirus-6 and HIV-1 Tat.
    Di Luca D, Secchiero P, Bovenzi P, Rotola A, Caputo A, Monini P, Cassai E.
    AIDS; 1991 Sep 26; 5(9):1095-8. PubMed ID: 1657039
    [Abstract] [Full Text] [Related]

  • 19. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
    Bieniasz PD, Grdina TA, Bogerd HP, Cullen BR.
    Proc Natl Acad Sci U S A; 1999 Jul 06; 96(14):7791-6. PubMed ID: 10393900
    [Abstract] [Full Text] [Related]

  • 20. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells.
    Kelly GD, Morris CB, Offermann MK.
    Virology; 1999 Oct 10; 263(1):128-38. PubMed ID: 10544088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.